Morning Overview on MSN
Scientists create a 'Trojan horse' obesity drug that hijacks GLP-1 receptors to smuggle a second weapon directly into fat cells
A single molecule that tricks its way into fat cells by mimicking a gut hormone, then releases a second drug once inside, has ...
Morning Overview on MSN
A next-generation 'Trojan horse' molecule outperformed every existing GLP-1 drug in mice — curbing appetite at lower doses with fewer side effects
The most prescribed weight-loss drugs on the market work by mimicking a single gut hormone. A hybrid molecule described in a ...
Zepbound and Ozempic are both prescription drugs part of the GLP-1 agonist drug class. While their uses are different, they do have some similarities, such as dosing schedule and form. This article ...
Originally developed to treat diabetes, a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are now stepping into the spotlight as weight loss drugs. A recent umbrella ...
SYDNEY, AUSTRALIA - JANUARY 13: Ozempic is medicine for adults with type 2 diabetes . Wegovy is prescribed for long-term weight loss in adults and children. Both contain the active ingredient ...
Glucagon-like peptide-1 (GLP-1) was first discovered in the 1980s as a regulator of glucose levels. Further research led to the creation of a stabilized GLP-1RA called semaglutide, the active ...
Meanwhile, peroxisome proliferation-activated receptors (PPARs) are obesity drug targets in their own right: activating them can reduce inflammation and restore insulin sensitivity. But molecules that ...
UBT251 is a drug that Novo Nordisk is developing with a Chinese company. It's a triple agonist drug that averaged nearly 20% weight loss over a 24-week trial. Improved growth prospects could give Novo ...
Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for type 2 diabetes and weight loss. Medications such as Ozempic, Wegovy, Mounjaro ...
Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have ...
Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results